Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Novara
Clinical trial register · Italy

Clinical Trials in Novara, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6778 matching records held by the registry are in this view. Synced 08 Oct 2026, 03:19 UTC
6778
Studies in scope
all four open statuses
4069
Recruiting now
open to new participants
1018
Lead sponsors
across recruiting studies
Top sites
Milan 2843 Bologna 1305 Roma 1274 Naples 984 Rome 967
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Azienda Ospedaliero Universitaria Maggiore della Carita8 Eli Lilly and Company6 Fondazione Italiana Linfomi - ETS5 BeOne Medicines5 Sanofi5
Site location
Milan2843 Bologna1305 Roma1274 Naples984 Rome967
All 489 locations
Target enrolment
to

Trials with a site in Novara

155 of 6778 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Not yet open
Colchicine Effect on Amyotrophic Lateral Sclerosis Patients
NCT07813858Amyotrophic Lateral Sclerosis
DrugColchicine
Azienda Ospedaliero-Universitaria di Modena
Phase 2
87
Milan, Modena, Naples, Novara, Pavia
2026-10
Not yet open
Fondazione EMN Italy Onlus
Observational
92
Bari, Bologna, Brescia, Castelfranco Veneto, Como, Milan, Novara, Pavia
2026-10
Recruiting
Azienda Ospedaliero Universitaria Maggiore della Carita
Observational
35
Novara
2026-09-10
Not yet open
Eli Lilly and Company
Phase 3
150
Florence, Modena, Novara, Parma, Roma
2026-09
Not yet open
IRCCS San Raffaele
Observational
50,000
Lecco, Milan, Novara, Varese
2026-07
Recruiting
Safety and Performances of the LINEA Cardiac Pacing Lead Optimized for the Implantation in Interventricular Septum
NCT07342608Bradycardia, Left Bundle Branch Area Pacing, Left Bundle Branch Pacing
MicroPort CRM
Not applicable
450
Novara, Pisa
2026-06-23
Recruiting
Janssen Research & Development, LLC
Phase 3
700
Bari, Bologna, Bolzano, Milan, Novara, Palermo, Pescara, Rimini
2026-05-31
Recruiting
BIO|STREAM.CSP CLS
NCT07608822Sinus Node Disease, Atrioventricular Block
Biotronik SE & Co. KG
Observational
150
Brindisi, Milan, Novara, Piove di Sacco, Roma, Taranto
2026-05-29
Recruiting
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
NCT07357727Primary Myelofibrosis (PMF), Post-polycythemia Vera Myelofibrosis (PPV-MF), Post-essential Thrombocythemia Myelofibrosis (PET-MF)
DrugsPelabresib·Ruxolitinib
Novartis Pharmaceuticals
Phase 3
460
Meldola, Florence, Padova, Roma, Verona, Novara
2026-05-27
Recruiting
BIO|STREAM.CSP Study
NCT07393009Cardiac Pacing, Cardiac Pacemaker, Implantable Cardioverter Defibrillator, Cardiac Resynchronization Therapy Devices
Biotronik SE & Co. KG
Observational
1,000
Brindisi, Milan, Novara, Piove di Sacco, Roma, Taranto
2026-05-25
Recruiting
Ipsen
Phase 3
350
Genova, Milan, Modena, Monza, Novara, Padova, Roma, Rozzano
2026-05-14
Recruiting
Merck Sharp & Dohme LLC
Phase 3
876
Bergamo, Milan, Florence, Perugia, Novara, Roma
2026-05-04
Not yet open
Association for Innovation and Biomedical Research on Light and Image
Observational
1,500
Milan, Novara
2026-05
Recruiting
Curis, Inc.
Phase 2
108
Milan, Novara, Padova
2026-04-23
Not yet open
Patient Satisfaction Study at AOU Maggiore Della Carità (SCORE)
NCT07471581Patient Satisfaction, Nursing, Nursing Care, Patient-Centered Care
Università degli Studi del Piemonte Orientale Amedeo Avogadro
Observational
250
Novara
2026-04-09
Recruiting
Sanofi
Phase 2/3
526
Torette, Milan, Rome, Bologna, Brescia, Novara
2026-03-13
Recruiting
Bristol-Myers Squibb
Phase 3
750
Ferrara (Cona), Aviano, Catania, Candiolo, Genova, Milan, Naples, Novara
2026-03-12
Recruiting
Meyer Children's Hospital IRCCS
Observational
500
Florence, Bergamo, Brescia, Catania, Lecce, Modena, Novara, Padova
2026-02-05
Recruiting
Eli Lilly and Company
Phase 3
300
Ancona, Florence, Messina, Naples, Novara, Padova, Verona
2026-02-05
Recruiting
ETOP IBCSG Partners Foundation
Phase 3
390
Meldola, Milan, Novara, Pavia, Perugia, Prato, Siena, Treviso
2026-01-12
Recruiting
Eli Lilly and Company
Phase 3
150
Ancona, Bologna, Cagliari, Florence, Milan, Naples, Novara, Padova
2026-01-12
Recruiting
Novo Nordisk A/S
Phase 3
460
Milan, Novara, Verona, Trieste
2026-01-08
Recruiting
Evaluation of the Quality of Care in the Emergency Department by Studying the Appropriateness of Hospitalizations
NCT06846879Quality of Care, Evaluation, Emergency Department, Appropriateness
Mario Negri Institute for Pharmacological Research
Observational
240,000
Alessandria, Cuneo, Novara, Novi Ligure, Orbassano, Rivoli, Torino
2026-01-05
Recruiting
Safety, Performance, and Clinical Benefit of Pacing the Left Bundle Branch Area - Post-Market Clinical Follow-up
NCT07209852Bradycardia, Atrioventricular Block, Sinus Node Dysfunction, Bundle-Branch Block
Boston Scientific Corporation
Observational
140
Ferrara, Milan, Novara
2025-12-19
Recruiting
Novo Nordisk A/S
Phase 3
332
Rome, Bergamo, Messina, Rivoli, Genova, Novara, Orbassano, San Donato Milanese
2025-12-18
Recruiting
European Myeloma Network B.V.
Phase 2
150
Ascoli Piceno, Bari, Bergamo, Bologna, Bolzano, Como, Milan, Novara
2025-12-12
Recruiting
ALX Oncology Inc.
Phase 2
120
Torrette, Genova, Bergamo, Bologna, Milan, Monza, Novara
2025-12-10
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Not applicable
1,260
Bari, Bologna, Catania, Ferrara, Milan, Novara, Palermo, Parma
2025-12-03
Recruiting
Hoffmann-La Roche
Phase 3
250
Naples, Cona (Ferrara), Rome, Milan, Novara, Palermo
2025-11-27
Recruiting
Sanofi
Observational
1,000
Ancona, Novara, Reggio Emilia, Roma
2025-11-17
Recruiting
Phase 2 Study of ADX-038 in Participants With Geographic Atrophy
NCT06990269Geographic Atrophy Secondary to Age-related Macular Degeneration
ADARx Pharmaceuticals, Inc.
Phase 2
240
Milan, Roma, Novara, Padova
2025-11-10
Recruiting
Acute DYSPnea in the Emergency Department: Diagnostic Value of Point-of-care UltraSound
NCT07324980Hydrostatic Pulmonary Edema, Acute Respiratory Failure, Dyspnea
Università degli Studi del Piemonte Orientale Amedeo Avogadro
Observational
200
Novara
2025-11-01
Recruiting
Pfizer
Phase 3
1,000
Meldola, Ravenna, Rozzano, Orbassano, Rome, Milan, Novara, Padova
2025-09-28
Recruiting
Alnylam Pharmaceuticals
Phase 3
11,000
Ancona, Cittadella, Lecco, L’Aquila, Messina, Milan, Naples, Novara
2025-09-22
Active, closed
Bristol-Myers Squibb
Phase 2
76
Meldola, Udine, Bergamo, Florence, Novara
2025-09-19
Recruiting
Bristol-Myers Squibb
Phase 2/3
600
Naples, Bologna, Aviano, Genoa, Pontedera, Prato, Milan, Novara
2025-09-11
Recruiting
Sanofi
Phase 3
90
Florence, Genoa, Milan, Naples, Meldola, Novara, Palermo, Trieste
2025-08-18
Recruiting
Takeda
Phase 3
150
Naples, Rome, Catania, Bologna, Milan, Monza, Novara, Torino
2025-08-14
Recruiting
Kedrion S.p.A.
Phase 3
40
Florence, Novara, Trieste, Torino, Vicenza
2025-08-13
Recruiting
Sanofi
Phase 3
723
Florence, Genoa, Milan, Rome, Turin, Bologna, Messina, Novara
2025-08-06
Recruiting
Association for Innovation and Biomedical Research on Light and Image
Phase 4
120
Milan, Novara, Roma, San Raffaele, Udine
2025-08-06
Not yet open
Humanitas Clinical and Research Center
Observational
45
Rozzano, Novara
2025-08-01
Recruiting
Azienda Ospedaliero Universitaria Maggiore della Carita
Not applicable
15
Novara
2025-06-24
Recruiting
Lung Ultrasound for Guiding Antibiotic Use in Pediatric Pneumonia
NCT06921993Pneumonia Childhood, Pneumonia, Lung Ultrasound, Antibiotic Stewardship
Meyer Children's Hospital IRCCS
Not applicable
659
Florence, Bergamo, Bologna, Brescia, Genova, Milan, Naples, Novara
2025-04-24
Recruiting
BeOne Medicines
Phase 3
250
Bari, Florence, Milan, Naples, Novara, Pavia, Perugia, Roma
2025-04-10
Recruiting
Mario Negri Institute for Pharmacological Research
Phase 2/3
246
Brescia, Bergamo, Milan, Naples, Novara, Padova, Palermo, Pergine Valsugana
2025-03-26
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,000
Rome, Bologna, Genova, Milan, Novara, Padova, Roma
2025-03-16
Recruiting
AstraZeneca
Phase 3
5,000
Bassano del Grappa, Bologna, Desio, Foggia, Genoa, Modena, Naples, Novara
2025-03-03
Recruiting
Takeda
Phase 3
171
Naples, Rome, Catania, Bologna, Milan, Monza, Novara, Torino
2025-02-27
Recruiting
Study on Plasmablastic Lymphoma Patients
NCT06781359Plasmablastic Lymphoma
Fondazione Italiana Linfomi - ETS
Observational
200
Aviano, Ascoli Piceno, Brescia, Cuneo, Florence, Milan, Monza, Novara
2025-02-14
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,046
Monza, Rionero in Vulture, Palermo, Candiolo, Ancona, Brescia, Milan, Novara
2025-01-27
Active, closed
Pfizer
Phase 3
1,035
Bologna, Meldola(FC), Rome, Florence, Milan, Novara, Padova, Roma
2025-01-06
Recruiting
Loxo Oncology, Inc.
Phase 2
249
Bari, Cona, Florence, Milan, Novara, Padova, Palermo, Perugia
2025-01-03
Active, closed
Daiichi Sankyo
Phase 3
700
Bari, Brescia, Meldola, Milan, Novara, Palermo, Roma, Rome
2024-11-19
Recruiting
Eli Lilly and Company
Phase 3
150
Florence, Novara, Verona
2024-11-18
Recruiting
Eli Lilly and Company
Phase 3
125
Florence, Modena, Novara, Parma, Roma, Verona
2024-11-18
By invitation
Mario Stirpe
Observational
400
Milan, Novara, Rome, Sassari, Genoa
2024-11-14
Recruiting
Azienda Ospedaliero Universitaria Maggiore della Carita
Observational
400
Novara
2024-10-30
Recruiting
The Sagittarius Trial
NCT06490536Colon Cancer Stage II, Colon Cancer Stage III
DrugsFolinic acid·Panitumumab·Pertuzumab·Temozolomide
IFOM ETS - The AIRC Institute of Molecular Oncology
Phase 3
700
Biella, Brescia, Genova, Milan, Rozzano, Novara, Parma, Perugia
2024-10-22
Recruiting
argenx
Phase 3
69
Bassano del Grappa, Florence, Milan, Novara, Ravenna, Reggio Emilia, Torino, Trieste
2024-10-18
Active, closed
Ipsen
Observational
424
Bergamo, Catania, Florence, Milan, Novara, Roma
2024-10-14
Recruiting
Boehringer Ingelheim
Phase 3
1,800
Bologna, Foggia, Milan, Modena, Novara, Palermo, Rome, Rozzano
2024-10-14
Active, closed
Regeneron Pharmaceuticals
Phase 2
151
Cuneo, Ferrara, Milan, Naples, Novara, Pisa, Rome, Taormina
2024-09-18
Recruiting
University of Eastern Piedmont
Not applicable
160
Novara
2024-09-01
Recruiting
An Extension Study for Patients Previously Enrolled in Studies With Pelabresib
NCT06401356Hematologic Malignancy, Solid Tumor, Advanced Malignancies
DrugPelabresib
Novartis Pharmaceuticals
Phase 3
50
Florence, Varese, Novara
2024-08-13
Active, closed
MedSIR
Phase 2
165
Bergamo, Milan, Novara, Roma
2024-07-22
Active, closed
Celgene
Phase 3
850
Ravenna, Rome, Palermo, Novara
2024-06-19
Recruiting
Merck Sharp & Dohme LLC
Phase 3
851
Naples, Rome, Milan, Monza, Rozzano, Brescia, Genova, Novara
2024-06-10
Active, closed
Janssen Research & Development, LLC
Phase 2
333
Bari, Ferrara, Florence, Milan, Novara, Padova, Palermo, Perugia
2024-05-30
Recruiting
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
NCT06419374Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
DrugPegozafermin
89bio, Inc.
Phase 3
762
Bergamo, Foggia, Milan, Novara, Palermo, Roma, Rome, Rozzano
2024-05-24
Recruiting
Fondazione Italiana Linfomi - ETS
Phase 2
28
Alessandria, Aviano, Bologna, Brescia, Milan, Naples, Novara, Palermo
2024-05-23
Active, closed
International Extranodal Lymphoma Study Group (IELSG)
Phase 3
122
Bari, Bologna, Brescia, Catania, Meldola, Milan, Novara, Palermo
2024-05-21
Active, closed
European Myeloma Network B.V.
Phase 2
50
Bari, Bergamo, Florence, Genova, Meldola, Novara, Padova, Pavia
2024-05-14
Active, closed
Fondazione Italiana Linfomi - ETS
Observational
56
Avellino, Alessandria, Biella, Milan, Novara, Pavia, Piacenza, Torino
2024-05-07
Recruiting
Karyopharm Therapeutics Inc
Phase 2
58
Milan, Orbassano, Torino, Bologna, Genova, Meldola, Novara, Pavia
2024-04-22
Active, closed
Amgen
Phase 3
434
Reggio Emilia, Udine, Rome, Milan, Novara, Florence, Verona, Catania
2024-04-08
Recruiting
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
NCT06318169Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
DrugPegozafermin
89bio, Inc.
Phase 3
1,350
Bergamo, Foggia, Milan, Modena, Naples, Novara, Palermo, Roma
2024-03-13
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
96
Bologna, Caserta, Catania, Ferrara, Florence, Milan, Novara, Palermo
2024-03-01
Recruiting
Amryt Pharma
Phase 4
12
Bologna, Catanzaro, Novara, Pisa, Udine
2024-02-08
Active, closed
Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21)
NCT05853575Advanced Cancer, Metastatic Cancer, Malignant Neoplasm of Lung
DrugAdagrasib
Mirati Therapeutics Inc.
Phase 2
200
Pesaro, Novara, Candiolo, Milan, Perugia, Roma
2024-02-01
Recruiting
Casa Sollievo della Sofferenza IRCCS
Phase 2
30
San Giovanni Rotondo, Novara, Padua, Palermo
2024-01-25
Recruiting
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
NCT06064877Metastatic Head-and-neck Squamous-cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma
DrugsErbitux·Cetuximab
AVEO Pharmaceuticals, Inc.
Phase 3
410
Bologna, Florence, Milan, Novara, Padua, Pavia, Roma
2024-01-11
Recruiting
Federico II University
Not applicable
100
Naples, Novara, Pisa, Roma
2023-12-29
Recruiting
Regeneron Pharmaceuticals
Phase 3
904
Meldola, Monza, Turin, Milan, Modena, Naples, Novara, Pavia
2023-12-13
Active, closed
Sanofi
Phase 2
197
Torette, Florence, Milan, Naples, Rome, Novara, Varese, Verona
2023-12-11
Active, closed
argenx
Observational
413
Florence, Gussago, Messina, Novara, Orbassano, Palermo, Pavia, Pisa
2023-11-29
Recruiting
Ibrutinib for the Treatment of AIHA in Patients With CLL/SLL or CLL-like MBL
NCT05694312Autoimmune Hemolytic Anemia, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Monoclonal B-Cell Lymphocytosis CLL-Type
DrugIbrutinib
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase 2
45
Florence, Novara, Torino
2023-11-24
Active, closed
GlaxoSmithKline
Phase 2
316
Rozzano, Bari, Bologna, Florence, Genova, Milan, Naples, Novara
2023-11-14
Active, closed
BeOne Medicines
Phase 3
652
Bologna, Ferrara, Milan, Novara, Padova, Perugia
2023-11-11
Active, closed
Ipsen
Observational
1,057
Foggia, Lecco, Milan, Novara, Salerno, Verona
2023-11-01
Active, closed
Eli Lilly and Company
Phase 3
160
Bologna, Verona, Messina, Novara
2023-10-16
Active, closed
Bristol-Myers Squibb
Phase 3
106
Reggio Calabria, Naples, Rome, Pavia, Rozzano (MI), Novara, Turin, Florence
2023-10-05
Recruiting
Susceptibility to Infectious Diseases in Obesity
NCT05975541Obesity, Type2diabetes, Gut Microbiota, Chronic Disease
Azienda Ospedaliero Universitaria Maggiore della Carita
Observational
80
Novara
2023-10-01
Recruiting
Identification of the Pathogenetic Mechanisms Underlying Squamous Cell Carcinomas
NCT06236464Squamous Cell Carcinoma of the Head and Neck, Squamous Cell Carcinoma of the Anus
National Cancer Institute, Naples
Observational
170
Bari, Naples, Novara, Pisa
2023-09-25
Recruiting
Hoffmann-La Roche
Phase 3
230
Meldola, Rome, Milan, Monza, Novara, Palermo, Bagno a Ripoli, Verona
2023-09-08
Active, closed
AnaptysBio, Inc.
Phase 2
420
Milan, Pavia, Bari, Novara, Roma
2023-08-31
Active, closed
Swedish Orphan Biovitrum
Observational
165
Bari, Bassano del Grappa, Bologna, Cagliari, Florence, Milan, Novara, Reggio Calabria
2023-06-26
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
65
Bologna, Caserta, Bari, Ferrara, Florence, Milan, Novara, Padova
2023-03-01
Active, closed
Fondazione Italiana Linfomi - ETS
Observational
160
Milan, Siena, Aviano, Brescia, Cuneo, Florence, Novara, Padova
2023-02-08
Active, closed
Novartis Pharmaceuticals
Phase 3
90
Milan, Bassano del Grappa, Novara
2022-12-30
Recruiting
Greenwich LifeSciences, Inc.
Phase 3
2,250
Bologna, Genova, Milan, Modena, Naples, Novara, Padova, Pavia
2022-12-16
Recruiting
IFOM ETS - The AIRC Institute of Molecular Oncology
Phase 2
37
Novara, Bergamo, Milan, Naples, Padova, Reggio Emilia
2022-12-15
Recruiting
The ROTAtional-USE of Interface STUDY
NCT05513508Pressure Ulcer, Noninvasive Positive Pressure Ventilation, Acute Hypercapnic Respiratory Failure
Azienda Ospedaliero Universitaria Maggiore della Carita
Not applicable
478
Novara
2022-12-08
Recruiting
Azienda Ospedaliero Universitaria Maggiore della Carita
Observational
108
Novara
2022-11-15
Active, closed
Effects of VLCKD in Metabolic Syndrome
NCT05275608Diabetes Mellitus, Type 2, Non-alcoholic Fatty Liver Disease, Obesity, Metabolic Syndrome
Azienda Ospedaliero Universitaria Maggiore della Carita
Not applicable
40
Novara
2022-11-07
Recruiting
GlaxoSmithKline
Phase 3
109
Bologna, Catania, Milan, Naples, Novara, Pavia, Roma, Treviso
2022-09-06
Active, closed
Bausch Health Americas, Inc.
Phase 3
466
Milan, Naples, Novara, Palermo, Rozzano
2022-08-03
Active, closed
Celgene
Phase 3
939
Rome, Bologna, Catania, Genova, Milan, Novara, Pavia, Pisa
2022-06-23
Active, closed
Fondazione Italiana Linfomi - ETS
Phase 2
49
Brescia, Alessandria, Cuneo, Florence, Genova, Milan, Naples, Novara
2022-03-21
Active, closed
BeOne Medicines
Phase 3
799
Aviano, Bologna, Florence, Milan, Novara, Padova, Pavia, Reggio Emilia
2022-03-10
Active, closed
Novartis Pharmaceuticals
Phase 3
1,000
Milan, Roma, Verona, Novara
2021-12-16
Active, closed
International Extranodal Lymphoma Study Group (IELSG)
Phase 2
26
Brescia, Milan, Novara, Ravenna, Reggio Emilia, Varese
2021-10-20
Active, closed
Fondazione Ricerca Traslazionale
Phase 2
105
Meldola, Saronno, Legnago, Negrar, Civitavecchia, Florence, Messina, Novara
2021-10-12
Active, closed
Loxo Oncology, Inc.
Phase 3
282
Rionero in Vulture, Bergamo, Brescia, Meldola, Milan, Monza, Novara, Perugia
2021-09-23
Active, closed
Inventiva Pharma
Phase 3
1,000
San Giovanni Rotondo, Milan, Naples, Palermo, Roma, Bologna, Novara, Torino
2021-08-19
Active, closed
Swiss Cancer Institute
Phase 2
260
Bergamo, Novara, Roma
2021-06-25
Recruiting
Poor Grade Aneurysmal Subarachnoid Hemorrhage Study Group
NCT04945603Subarachnoid Hemorrhage, Aneurysmal, Poor Grade Subarachnoid Hemorrhage
IRCCS San Raffaele
Observational
800
Bergamo, Bologna, Brescia, Lecce, Milan, Novara, Parma, Roma
2021-05-25
Active, closed
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
100
Bologna, San Giovanni Rotondo, Bari, Cagliari, Novara, Palermo, Reggio Emilia, Terni
2021-05-20
Active, closed
Hoffmann-La Roche
Observational
800
Taranto, Reggio Calabria, Meldola, Rome, Genoa, Brescia, Cremona, Novara
2021-05-10
Active, closed
Incyte Corporation
Phase 3
654
Bari, Brescia, Candiolo, Catania, Lecce, Milan, Naples, Novara
2021-04-15
Active, closed
Karyopharm Therapeutics Inc
Phase 3
353
Catania, Meldola, Genova, Milan, Monza, Novara, Rionero in Vulture, Roma
2021-03-11
Recruiting
AB Science
Phase 3
495
Baggiovara, Brescia, Gussago, Milan, Novara, Padova, Pavia, Torino
2021-02-02
Active, closed
AstraZeneca
Phase 3
1,371
Bergamo, Florence, Milan, Modena, Naples, Novara, Padova, Parma
2021-01-28
Active, closed
Genmab
Phase 3
483
Bari, Bergamo, Brescia, Meldola, Milan, Novara, Pavia, Ravenna
2021-01-13
Active, closed
Acerta Pharma BV
Phase 3
611
Bari, Bergamo, Bologna, Florence, Genova, Meldola, Milan, Novara
2020-10-08
Active, closed
European Myeloma Network B.V.
Phase 3
302
Ancona, Bari, Bologna, Brescia, Cuneo, Florence, Novara, Pavia
2020-09-25
Active, closed
Karyopharm Therapeutics Inc
Phase 2/3
501
Ancona, Caserta, Naples, Novara, Pescara, Rome, Palermo, Turin
2020-09-03
Active, closed
Incyte Corporation
Phase 2
112
Bologna, Florence, Meldola (FC), Milan, Naples, Novara, Palermo, Pisa
2020-08-03
Recruiting
IFOM ETS - The AIRC Institute of Molecular Oncology
Observational
1,500
Bergamo, Milan, Novara, Padova, Pavia, Roma, Reggio Emilia
2020-07-16
Recruiting
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
NCT04256317Myelodysplastic Syndromes, Acute Myeloid Leukemia, Myelodysplastic Syndrome/Neoplasm, Chronic Myelomonocytic Leukemia
DrugsVenclexta·Azacitidine·Venetoclax
Taiho Oncology, Inc.
Phase 2/3
316
Ravenna, Florence, Torino, Bologna, Milan, Novara, Roma
2020-05-21
Active, closed
BeOne Medicines
Phase 3
955
Bologna, Meldola, Milan, Modena, Novara, Ravenna, Roma, Terni
2020-01-16
Active, closed
Cold Agglutinin Disease Real World Evidence Registry
NCT05791708Cold Agglutinin Disease (CAD), Cold Agglutinin Syndrome (CAS)
RECORDATI GROUP
Observational
429
Brescia, Campobasso, Novara, Palermo, Pavia, Ravenna, Reggio Calabria, Roma
2019-12-12
Active, closed
Regeneron Pharmaceuticals
Phase 2
515
Milan, Bologna, Livorno, Novara, Perugia, Ravenna, Reggio Emilia, Varese
2019-11-13
Active, closed
AbbVie
Phase 1/2
218
Bologna, Milan, Novara, Meldola
2019-11-06
By invitation
Rigel Pharmaceuticals
Phase 3
90
Milan, Novara
2019-10-30
Active, closed
Niguarda Hospital
Phase 2
28
Alessandria, Bergamo, Bologna, Brescia, Milan, Novara, Pavia, Roma
2019-10-04
Active, closed
Study to Compare the Efficacy and Safety of NT 201 (Botulinum Toxin) With Placebo for the Treatment of Lower Limb Spasticity Caused by Stroke or Traumatic Brain Injury
NCT03992404Lower Limb or Combined Lower Limb and Upper Limb Spasticity Due to Stroke or Traumatic Brain Injury
DrugXeomin
Merz Pharmaceuticals GmbH
Phase 3
603
Foggia, Genova, Novara, Terracina
2019-09-16
Active, closed
ETOP IBCSG Partners Foundation
Phase 3
405
Aviano, Bergamo, Brindisi, Meldola, Milan, Novara, Parma, Pavia
2019-08-27
Active, closed
BeOne Medicines
Phase 3
510
Alessandria, Bologna, Genova, Milan, Novara, Palermo, Pisa, Ravenna
2019-08-20
Active, closed
Janssen Research & Development, LLC
Phase 2/3
118
Ascoli Piceno, Brescia, Catania, Florence, Milan, Monza, Novara, Roma
2019-08-15
Active, closed
Fondazione EMN Italy Onlus
Phase 2
45
Ancona, Bari, Bergamo, Bologna, Brescia, Catania, Milan, Novara
2019-07-01
Active, closed
European Myeloma Network B.V.
Phase 2
401
Ancona, Bergamo, Bologna, Brescia, Catania, Genova, Milan, Novara
2019-04-16
Active, closed
Madrigal Pharmaceuticals, Inc.
Phase 3
1,759
Messina, Milan, Novara, Palermo, Roma, Bergamo, Florence, Pisa
2019-03-28
Active, closed
Acerta Pharma BV
Phase 3
984
Meldola, Milan, Novara, Ravenna, Torino
2019-02-25
Active, closed
Gilead Sciences
Phase 2
502
Arezzo, Aviano, Cremona, Genoa, Meldola, Milan, Novara, Padova
2018-08-13
Recruiting
Xynomic Pharmaceuticals, Inc.
Phase 3
413
Candiolo, Catania, Meldola (FC), Milan, Naples, Novara, Pavia, Pisa
2018-07-17
Active, closed
Exelixis
Phase 3
837
Tricase, Rozzano, Bologna, Brescia, Milan, Naples, Novara, Roma
2018-06-10
Recruiting
Azienda Ospedaliero Universitaria Maggiore della Carita
Observational
400
Novara
2018-06-01
Active, closed
Oncology Institute of Southern Switzerland
Observational
370
Reggio Emilia, Novara
2018-03-01
Recruiting
Registry for Patients With Lipodystrophy
NCT03553420Lipodystrophy Acquired, Lipodystrophy Congenital
University of Ulm
Observational
5,000
Bologna, Milan, Novara, Palermo, Pisa, Roma
2017-12-16
Active, closed
Hoffmann-La Roche
Phase 3
382
Naples, Modena, Rome, Genoa, Milan, Monza, Novara, Orbassano
2017-09-20
Recruiting
MEASuRE: Metreleptin Effectiveness And Safety Registry
NCT02325674Generalised Lipodystrophy, Partial Lipodystrophy
DrugMetreleptin
Chiesi Farmaceutici S.p.A.
Observational
100
Bologna, Pisa, Roma, Novara
2016-10-11
Active, closed
Acerta Pharma BV
Phase 2
124
Bologna, Meldola, Milan, Novara
2015-03-02
Active, closed
Karyopharm Therapeutics Inc
Phase 2
244
Bologna, Florence, Naples, Novara, Rome, Siena, Torino
2014-11
Active, closed
Acerta Pharma BV
Phase 2
107
Bologna, Milan, Novara
2014-09-11
Rows per page Showing 1–155 of 155
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 10 October 2026. https://priyalifescience.com/clinical-trials-italy/city/novara

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,778 studies in total at the last sync on 08 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 155 of those studies with a site in Novara.

How many clinical trials are recruiting in Novara?

81 of the 155 studies on this page are recruiting new participants as of the 08 Oct 2026, 03:19 UTC sync. A further 7 have not yet opened recruitment, 65 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Novara), 155 studies
PhaseStudiesRecruitingShare
Phase 3693844.5%
Observational362023.2%
Phase 2331021.3%
Not applicable875.2%
Phase 2/3643.9%
Phase 4221.3%
Phase 1/2100.6%

Most active sponsors

Lead sponsors with the most studies (Novara)
Lead sponsorStudiesRecruiting
Azienda Ospedaliero Universitaria Maggiore della Carita87
Eli Lilly and Company64
BeOne Medicines51
Fondazione Italiana Linfomi - ETS52
Sanofi54
Acerta Pharma BV40
Bristol-Myers Squibb42
European Myeloma Network B.V.41
Hoffmann-La Roche42
IRCCS Azienda Ospedaliero-Universitaria di Bologna43
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.